BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
火曜日, 9 29

Quest Diagnostics Inc

DGXNYSE
Trade with Public
Trade with Public
$237.62
1.300.55%
近くで: Sep 25, 5:00 PM EST
$237.62
1.300.55%
プレマーケット: 4:44 AM EST
配当金: 配当落ち日は7 日後です。
概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Quest Diagnostics Financials

Quest Diagnostics (DGX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidance gets a boost.
Vandana Singh

Earnings Scheduled For July 23, 2026

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report
Benzinga Insights

PRO
Quest Diagnostics Raises FY2026 Adj EPS Guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 Est; Raises FY2026 Sales Guidance from $11.780B-$11.900B to $11.950B-$12.050B vs $11.851B Est

Quest Diagnostics (NYSE:DGX) raises FY2026 Adj EPS guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 analyst estimate. Raises FY2026 sales outlook from $11.780 billion-$11.900 billion to $11.950 billion-$12.050
Benzinga Newsdesk

PRO
Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.58-$9.78 to $9.97-$10.17 vs $9.60 Est

Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.58-$9.78 to $9.97-$10.17 vs $9.60 analyst estimate..
Benzinga Newsdesk

PRO
Quest Diagnostics Q2 Adj. EPS $3.12 Beats $2.83 Estimate, Sales $3.043B Beat $2.973B Estimate

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $3.12 per share which beat the analyst consensus estimate of $2.83 by 10.25 percent. This is a 19.08 percent increase over earnings of $2.62 per share from the
Benzinga Newsdesk

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Quest Diagnostics (DGX) reported strong Q1 earnings, beating expectations and raising guidance. Analysts maintain positive outlook on stock.
Avi Kapoor

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved